Sign Up to like & get recommendations! 1
Published in 2022 at "Advanced Science"
DOI: 10.1002/advs.202202206
Abstract: Transarterial chemoembolization (TACE) is the major treatment for advanced hepatocellular carcinoma (HCC), but it may cause hypoxic environment, leading to rapid progression after treatment. Here, using high‐throughput sequencing on different models, S100 calcium binding protein… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Cancer"
DOI: 10.1002/cncr.33677
Abstract: The efficacy and safety of transarterial chemoembolization (TACE) plus lenvatinib in patients with hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT) have not been evaluated. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Nursing Open"
DOI: 10.1002/nop2.1529
Abstract: Post‐embolization syndrome is a common adverse event following trans‐arterial chemoembolization, which negatively impacts the daily life of the patients involved. This study examined whether perceptions around post‐embolization syndrome and symptom interference among nurses affect their… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "CardioVascular and Interventional Radiology"
DOI: 10.1007/s00270-020-02609-z
Abstract: Topotecan is a camptothecin analogue with potential advantages over irinotecan for transarterial chemoembolization (TACE) of hepatic colorectal metastases including greater anti-neoplastic activity without enzymatic activation. The purpose of this study was to assess safety and… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-019-05733-0
Abstract: Background There is lack of data for identifying optimal local therapy for the management of recurrent hepatocellular carcinoma (HCC) after hepatic resection. Aims A retrospective study was performed to compare the effectiveness of transarterial chemoembolization… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-019-05951-6
Abstract: Background The purpose of this study was to assess the value of functional MRI (fMRI) of post-doxorubicin drug-eluting beads transcatheter arterial chemoembolization (DEB-TACE) for hepatocellular carcinoma (HCC) as an early imaging biomarker of response to… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Japanese journal of clinical oncology"
DOI: 10.1093/jjco/hyz129
Abstract: BACKGROUNDS The incidence of acute kidney injury and the association between acute kidney injury and prognosis have been reported about transcatheter arterial chemoembolization using anthracycline. However, the incidence of acute kidney injury after platinum-based transarterial… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Medicine"
DOI: 10.1097/md.0000000000008634
Abstract: Abstract The purpose of the study was to evaluate the value of transarterial chemoembolization (TACE) via right internal thoracic artery (RITA) for patients with unresectable hepatocellular carcinoma (HCC). From January 2000 to June 2016, a… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "IEEE Transactions on Biomedical Engineering"
DOI: 10.1109/tbme.2022.3151819
Abstract: Objective: Superparamagnetic nanoparticles (SPIONs) can be combined with tumor chemoembolization agents to form magnetic drug-eluting beads (MDEBs), which are navigated magnetically in the MRI scanner through the vascular system. We aim to develop a method… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Hepatology Research"
DOI: 10.1111/hepr.13801
Abstract: Tyrosine kinase inhibitors target transarterial chemoembolization (TACE)‐mediated vascular endothelial growth factor to inhibit tumor revascularization and to slow tumor progression. The present study aimed to compare the clinical outcomes of TACE combined with lenvatinib (TACE‐lenvatinib)… read more here.